ABG Sundal Collier - News
ABG Sundal Collier - Nanexa - Adding another layer to drug development
28/20 – Information regarding the rights issue from Nanexa AB
Nanexa AB - NEX-18
Nanexa
23/19 – Last day of trading in Nanexa AB subscription option
Lindahl biträder Nanexa i kapitalanskaffning - Dagens Juridik
Nanexa AB (@AbNanexa) / Twitter
Nanexa AB (@AbNanexa) / Twitter
Nanexa AB - NEX-18
G&W Digital Småbolagsfrukost - Lipigon Pharmaceuticals AB
Nanexa: närmar sig kliniska prövningar för unik drug delivery-metod | Placera
Nanexa
Nanexa AB (@AbNanexa) / Twitter
Nanexa AB (@AbNanexa) / Twitter
Annual report 2021
ABG Sundal Collier - Nanexa - NEX-18 study put on pause
INTERIM REPORT January – June 2022
Nanexa AB (@AbNanexa) / Twitter
133/20 – Nanexa AB will be delisted after close of the market on May 28, 2020
Nanexa AB - Hem
